Skip to main content
Articles

grit42 and its collaborator Fraunhofer are leading the way in the digital fight against AntiMicrobial Resistance


April 06, 2022

Today Fraunhofer and grit42 announced that their collaboration across multiple AntiMicrobial Resistance (AMR) projects – funded by the Innovative Medicines Initiative (IMI) – has made significant ...

Read More
December 23, 2021 • 1 min read
Merry Christmas from grit42. And Slartibartfast.

We wish all of our customers, partners, family, friends, and designers of Norwegian fjords a very merry Christmas and a happy new year!
December 14, 2021 • 2 min read
Contera Pharma selects grit42 for scientific data management

Copenhagen, Denmark — December 14, 2021 — Today grit42 announces that its platform for scientific data management and analysis, has been selected by Contera Pharma, a biotech company developing innovative therapies to treat neurological disorders.

Articles
December 23, 2020 • 1 min read
Merry Christmas from grit42. And Zaphod Beeblebrox.

What a strange year. And what could be more fitting than making a special custom LEGO minifigure of Zaphod Beeblebrox. The character behind the famous words:
January 29, 2020 • 3 min read
ERA4TB, an international consortium to accelerate the development of comprehensive treatments against tuberculosis

AMR, Uncategorized, IMI
December 17, 2019 • 1 min read
Merry Christmas from grit42. And Marvin.

December 03, 2019 • 3 min read
New IMI project “COMBINE” launched to accelerate the fight against antimicrobial resistance

Articles
November 17, 2019 • 1 min read
Strengthening our commitment to help tackle antimicrobial resistance, we’re joining the BEAM Alliance

Articles
August 27, 2019 • 2 min read
Fraunhofer and grit42 join forces in the global fight against antimicrobial resistance

Articles
August 01, 2019 • 2 min read
The IMI-backed project ‘GNA NOW’ kicks off its battle against antimicrobial resistance

New partnership will advance three antibacterial programmes as part of the Innovative Medicines Initiative (IMI), a public-private European R&D consortium.

Articles